4 research outputs found
A human immune system (HIS) mouse model that dissociates roles for mouse and human FcR + cells during antibodyâmediated immune responses
Human immune system (HIS) mice provide a model to study human immune responses in vivo. Currently available HIS mouse models may harbor mouse Fc Receptor (FcR)âexpressing cells that exert potent effector functions following administration of human Ig. Previous studies showed that the ablation of the murine FcR gamma chain (FcRâÎł) results in loss of antibodyâdependent cellular cytotoxicity and antibodyâdependent cellular phagocytosis in vivo. We created a new FcRâÎłâdeficient HIS mouse model to compare host (mouse) versus graft (human) effects underlying antibodyâmediated immune responses in vivo. FcRâÎłâdeficient HIS recipients lack expression and function of mouse activating FcRs and can be stably and robustly reconstituted with human immune cells. By screening blood Bâcell depletion by rituximab Ig variants, we found that human FcÎłRsâmediated IgG1 effects, whereas mouse activating FcÎłRs were dominant in IgG4 effects. Complement played a role as an IgG1 variant (IgG1 K322A) lacking complement binding activity was largely ineffective. Finally, we provide evidence that FcÎłRIIIA on human NK cells could mediate complementâindependent Bâcell depletion by IgG1 K322A. We anticipate that our FcRâÎłâdeficient HIS model will help clarify mechanisms of action of exogenous administered human antibodies in vivo
Chronic viral infection promotes efficient germinal center B cell responses
Persistent viral infections subvert key elements of adaptive immunity. To compare germinal center (GC) B cell responses in chronic and acute lymphocytic choriomeningitis virus infection, we exploit activation-induced deaminase (AID) fate-reporter mice and perform adoptive B cell transfer experiments. Chronic infection yields GC B cell responses of higher cellularity than acute infections do, higher memory B cell and antibody secreting cell output for longer periods of time, a better representation of the late B cell repertoire in serum immunoglobulin, and higher titers of protective neutralizing antibodies. GC B cells of chronically infected mice are similarly hypermutated as those emerging from acute infection. They efficiently adapt to viral escape variants and even in hypermutation-impaired AID mutant mice, chronic infection selects for GC B cells with hypermutated B cell receptors (BCRs) and neutralizing antibody formation. These findings demonstrate that, unlike for CD8+ TÂ cells, chronic viral infection drives a functional, productive, and protective GC B cell response
Epitope convergence of broadly HIV-1 neutralizing IgA and IgG antibody lineages in a viremic controller
International audienceDecrypting the B cell ontogeny of HIV-1 broadly neutralizing antibodies (bNAbs) is paramount for vaccine design. Here, we characterized IgA and IgG bNAbs of three distinct B cell lineages in a viremic controller, two of which comprised only IgG+ or IgA+ blood memory B cells; the third combined both IgG and IgA clonal variants. 7-269 bNAb in the IgA-only lineage displayed the highest neutralizing capacity despite limited somatic mutation, and delayed viral rebound in humanized mice. bNAbs in all three lineages targeted the N332 glycan supersite. The 2.8-Ă
resolution cryo-EM structure of 7-269-BG505 SOSIP.664 complex showed a similar pose as 2G12, on an epitope mainly composed of sugar residues comprising the N332 and N295 glycans. Binding and cryo-EM structural analyses showed that antibodies from the two other lineages interact mostly with glycans N332 and N386. Hence, multiple B cell lineages of IgG and IgA bNAbs focused on a unique HIV-1 site of vulnerability can codevelop in HIV-1 viremic controllers